The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.
 
Yuval Shaked
Stock and Other Ownership Interests - Oncohost; RemedyCell
Consulting or Advisory Role - Oncohost; RemedyCell
 
Madeleine Benguigui
No Relationships to Disclose
 
Ruth Halaban
No Relationships to Disclose
 
Antonella Bacchiocchi
No Relationships to Disclose
 
Iris Kamer
No Relationships to Disclose
 
Jair Bar
Stock and Other Ownership Interests - Causalis
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Roche/Genentech; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Michal Lotem
Patents, Royalties, Other Intellectual Property - Using slamf6 immune receptor Modulation of slamf6 splice variants for cancer therapy WO 2019/155474 A1 11/02/2019 (Pending)
 
Shai Shen-Orr
Leadership - Cytoreason
Stock and Other Ownership Interests - Cytoreason
Honoraria - Pfizer
Consulting or Advisory Role - Cytoreason
Patents, Royalties, Other Intellectual Property - Cytoreason
 
Mario Sznol
Stock and Other Ownership Interests - Actym Therapeutics; Adaptive Biotechnologies; Amphivena; Asher Biotherapeutics; EvolveImmune Therapeutics; GlaxoSmithKline; Intensity Therapeutics; Johnson & Johnson/Janssen; Nextcure; Normunity; Oncohost; Repertoire Immune Medicines; Rootpath
Consulting or Advisory Role - Adagene; Adaptimmune; Agenus; Alligator Bioscience; AnaptysBio; AstraZeneca/MedImmune; Biond Biologics; BioNTech; Bristol-Myers Squibb; Dragonfly Therapeutics; Genocea Biosciences; Gilead Sciences; immunocore; Innate Pharma; Iovance Biotherapeutics; ITeos Therapeutics; Jazz Pharmaceuticals; Kadmon; Kanaph Therapeutics; Merck; Molecular Partners; Numab; Ocellaris Pharma; OncoSec; Pfizer; Pierre Fabre; PIOtx; Pliant; Regeneron; Sapience Therapeutics; Seagen; Simcha Therapeutics; Simcha Therapeutics; ST Cube; Targovax; Tessa Therapeutics; Turnstone Bio; Verastem; Xilio Therapeutics
Other Relationship - CEC Oncology; Physicans' Education Resource
 
Tim J Cooper
No Relationships to Disclose